International Clinical Trial: An Exploratory, Single-Arm Study of Adebrelimab and Famitinib for Locally Advanced Head and Neck Squamous Cell Carcinoma

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120413) titled 'An Exploratory, Single-Arm Study of Adebrelimab and Famitinib for Locally Advanced Head and Neck Squamous Cell Carcinoma' on March 13.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Shandong Second Provincial General Hospital

Condition: Head and neck squamous cell carcinoma

Intervention: Trial Group:Adebrelimab 1200mg, intravenous infusion, on Cycle Day 1 for 3 cycles

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-15

Target Sample Size: Trial Group:30;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showpr...